GMRE Share Price | Global Medical REIT, Inc. Stock Analysis & Recommendation

Q: How big is Global Medical REIT, Inc.?

Market Cap: As of Jun 18, Global Medical REIT, Inc. has a market capitalization of 451.94 million, categorizing it as a Micro Cap company.Recent Quarterly Performance: For the latest four quarters, the company reported net sales of 154.28 million and a net profit of 8.12 million.Balance Sheet Snapshot: As of Dec 24, the company's shareholder's funds amounted to 534.13 million, while total assets were reported at 1,256.49 million.

Q: What does Global Medical REIT, Inc. do?

Overview: Global Medical REIT, Inc. is engaged primarily in the acquisition of licensed, purpose-built healthcare facilities and leasing these facilities to clinical operators, operating within the Realty industry and classified as a Micro Cap company.Financial Snapshot: Most recent Net Sales: 38 Million (Quarterly Results - Mar 2025) Most recent Net Profit: 4 Million (Quarterly Results - Mar 2025) Market-cap: USD 451.94 Million (Micro Cap)Key Metrics: P/E: 48.00 Dividend Yield: 3.11% Debt Equity: -999,999.00 Return on Equity: 1.86% Price to Book: 0.87Contact Details: Address: 2 Bethesda Metro Ctr Ste 440, BETHESDA MD: 20814-5333 Tel: 1 202 5246851 Website: http://www.globalmedicalreit.com/

Q: Is Global Medical REIT, Inc. overvalued or undervalued?

As of 3 August 2021, the valuation grade for Global Medical REIT, Inc. moved from risky to very attractive, indicating a significant improvement in its investment appeal. The company appears undervalued, particularly when considering its Price to Book Value of 0.89 and an EV to EBITDA ratio of 4.35, which are favorable compared to its peers. Additionally, the P/E ratio stands at 48, which is higher than the peer average of approximately 46.20 for similar companies like Armada Hoffler Properties, Inc. and New York Mortgage Trust, Inc., both of which also have attractive valuations.In terms of peer comparison, Global Medical REIT, Inc. has a lower EV to EBITDA than Brandywine Realty Trust, which is at 2.49, suggesting it may be undervalued relative to its earnings potential. Despite a challenging return profile over longer periods, where it has underperformed the S&P 500 (with a 1-year return of -23.77% versus 17.14% for the index), its recent 1-month return of 16.07% compared to the S&P 500's 2.33% indicates a potential turnaround.

Q: Is Global Medical REIT, Inc. technically bullish or bearish?

As of 11 August 2025, the technical trend for Global Medical REIT, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating a bearish trend, while the weekly MACD and KST show mildly bullish signals. The Bollinger Bands on a weekly basis are bullish, but monthly indicators remain bearish. Overall, the mixed signals suggest caution.In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 1.18% and 16.07% respectively, but it has significantly underperformed over the longer term, with a 1-year return of -23.77% compared to the S&P 500's 17.14%.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

52.74 k

Shareholding (Dec 2025)

FII

5.69%

Held by 84 FIIs

DII

57.2%

Held by 39 DIIs

Promoter

0.00%

How big is Global Medical REIT, Inc.?

22-Jun-2025

As of Jun 18, Global Medical REIT, Inc. has a market capitalization of 451.94 million, with net sales of 154.28 million and a net profit of 8.12 million over the last four quarters. The company's total assets are reported at 1,256.49 million, with shareholder's funds of 534.13 million.

View full answer

What does Global Medical REIT, Inc. do?

22-Jun-2025

Global Medical REIT, Inc. acquires and leases licensed healthcare facilities to clinical operators. It has a market cap of $451.94 million, with recent net sales of $38 million and a net profit of $4 million.

View full answer

Who are in the management team of Global Medical REIT, Inc.?

22-Jun-2025

As of March 2022, the management team of Global Medical REIT, Inc. includes Mr. Jeffrey Busch as Chairman, President, and CEO, with Ms. Huiqi Zhang and Mr. Jingguo Zhang as Directors, and Mr. Henry Cole, Ms. Paula Crowley, and Dr. Matthew Cypher as Independent Directors.

View full answer

Is Global Medical REIT, Inc. overvalued or undervalued?

20-Sep-2025

As of August 3, 2021, Global Medical REIT, Inc. is considered very attractive due to its undervaluation indicated by a Price to Book Value of 0.89 and an EV to EBITDA ratio of 4.35, despite a higher P/E ratio of 48 compared to peers, and while it has underperformed the S&P 500 over the long term, it recently showed a potential turnaround with a 1-month return of 16.07%.

View full answer

Is Global Medical REIT, Inc. technically bullish or bearish?

20-Sep-2025

As of August 11, 2025, Global Medical REIT, Inc. shows a mildly bearish trend with mixed signals from technical indicators, having outperformed the S&P 500 in the short term but significantly underperformed over the past year.

View full answer

Compare Global Medical REIT, Inc. with Similar Stocks

Peakstone Realty Trust Summit Hotel Properties, Inc.Dynex Capital, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Negative results in Jun 25

PRE-TAX PROFIT(Q) At USD 0.58 MM has Fallen at -76.15%
NET PROFIT(Q) At USD 0.66 MM has Fallen at -72.82%
DEBT-EQUITY RATIO (HY) Highest at 143.66 %

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Realty

Market cap

USD 493 Million (Micro Cap)

P/E

47.00

Industry P/E

Dividend Yield

44.72%

Debt Equity

-999,999.00

Return on Equity

2.16%

Price to Book

1.02

Revenue and Profits:

Net Sales:

41 Million

(Quarterly Results - Dec 2025)

Net Profit:

-6 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-0.33%

6 Months

-1.16%

1 Year

-21.37%

2 Years

-20.34%

3 Years

292.66%

4 Years

109.34%

5 Years

153.86%

Global Medical REIT, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

12.32%

EBIT Growth (5y)

35.54%

EBIT to Interest (avg)

1.53

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

6,829.27%

Pledged Shares

Institutional Holding

79.90%

ROCE (avg)

7.78%

ROE (avg)

2.27%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.02

EV to EBIT

10.20

EV to EBITDA

4.59

EV to Capital Employed

1.02

EV to Sales

3.04

PEG Ratio

0.05

Dividend Yield

44.72%

ROCE (Latest)

9.96%

ROE (Latest)

2.16%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 63 Schemes (36.95%)

Foreign Institutions

Held by 84 Foreign Institutions (5.69%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 1.72% vs -1.69% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -19.61% vs -950.00% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "41.30",
          "val2": "40.60",
          "chgp": "1.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "27.20",
          "val2": "27.50",
          "chgp": "-1.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "11.30",
          "val2": "11.50",
          "chgp": "-1.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.70",
          "val2": "-6.30",
          "chgp": "-6.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.10",
          "val2": "-5.10",
          "chgp": "-19.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "298.00%",
          "val2": "307.40%",
          "chgp": "-0.94%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 3.21% vs -0.45% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -202.99% vs -69.12% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "161.00",
          "val2": "156.00",
          "chgp": "3.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "108.40",
          "val2": "105.40",
          "chgp": "2.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "44.60",
          "val2": "45.90",
          "chgp": "-2.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-13.00",
          "val2": "-1.70",
          "chgp": "-664.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.90",
          "val2": "6.70",
          "chgp": "-202.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "306.60%",
          "val2": "321.10%",
          "chgp": "-1.45%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

41.30

40.60

1.72%

Operating Profit (PBDIT) excl Other Income

27.20

27.50

-1.09%

Interest

11.30

11.50

-1.74%

Exceptional Items

-6.70

-6.30

-6.35%

Consolidate Net Profit

-6.10

-5.10

-19.61%

Operating Profit Margin (Excl OI)

298.00%

307.40%

-0.94%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 1.72% vs -1.69% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -19.61% vs -950.00% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

161.00

156.00

3.21%

Operating Profit (PBDIT) excl Other Income

108.40

105.40

2.85%

Interest

44.60

45.90

-2.83%

Exceptional Items

-13.00

-1.70

-664.71%

Consolidate Net Profit

-6.90

6.70

-202.99%

Operating Profit Margin (Excl OI)

306.60%

321.10%

-1.45%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 3.21% vs -0.45% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -202.99% vs -69.12% in Dec 2024

All Annual Results

Company CV

About Global Medical REIT, Inc.

Global Medical REIT, Inc.

Realty

Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, purpose-built healthcare facilities and the leasing of these facilities to clinical operators with market share. The Company’s strategy is to produce increasing, reliable rental revenue by expanding its portfolio, and leasing its healthcare facilities to market operators under long-term triple-net leases.

Company Coordinates

Company Details

2 Bethesda Metro Ctr Ste 440 , BETHESDA MD : 20814-5333

Tel: 1 202 5246851

http://www.globalmedicalreit.com/

Registrar Details